Antibacterial gynecological composition, preparation and preparation method

By using compositions of natural plant extracts such as hesperidin, big green leaves, nanosilver ion-chitosan complexes and snail mucus antibacterial peptides, a variety of pathogenic microorganisms and drug resistance in the treatment of mixed vaginitis were solved. Sexual problems have achieved effective prevention and treatment of mixed vaginitis and promoted the recovery of vaginal microecology.

CN118949016AInactive Publication Date: 2024-11-15GUANGZHOU GREENWALL BIOMEDICAL TECH CO LTD
View PDF 10 Cites 0 Cited by

Patent Information

Application Number
CN202411058592.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-02
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing treatments are difficult to effectively treat mixed vaginitis, especially due to the complexity and drug resistance problems caused by the combined action of multiple pathogenic microorganisms. Traditional antibiotic treatment is prone to the generation of drug-resistant strains and it is difficult to fully cover all pathogens.

Method used

An antibacterial gynecological composition is adopted, including hesperidin, large green leaves, pinelan root, Houttuynia cordata and other natural plant extracts, combined with nano-silver ion-chitosan complex and snail mucus antibacterial peptides, forming multiple targets and multiple targets. Mechanistic antibacterial system used to prepare suppositories, lotions, gels, sprays or ointments for the prevention and treatment of mixed vaginitis.

Benefits of technology

This composition can not only effectively inhibit and kill a variety of pathogenic bacteria, but also promote the recovery of vaginal microecology balance, improve the body's immunity, significantly improve the prevention and treatment effect of mixed vaginitis, and through preclinical research and Preliminary clinical trials have verified its safety and efficacy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004977131490000081
    Figure BDA0004977131490000081
  • Figure BDA0004977131490000091
    Figure BDA0004977131490000091
  • Figure BDA0004977131490000111
    Figure BDA0004977131490000111
Patent Text Reader

Abstract

The invention provides an antibacterial gynecological composition, a preparation and a preparation method. The composition comprises the following active ingredients: hesperidin, folium isatidis, radix isatidis, houttuynia cordata, paris polyphylla, dandelion, folium artemisiae argyi, allicin, lysozyme, shikimic acid, gallic acid, purslane extract and the like. The composition can also comprise a nano-silver ion-chitosan compound, tea tree polysaccharide and snail mucus antibacterial peptide. The nano-silver ion-chitosan compound is prepared through the steps of dissolving chitosan with specific acetic acid concentration and the like, and the snail mucus antibacterial peptide is obtained by adjusting the pH value of snail mucus, then carrying out enzymolysis reaction and the like. The preparation method comprises the following steps: treating the Chinese herbal medicines, performing water extraction to obtain an extract, adding various active components, mixing, drying, crushing, sieving, sterilizing, packaging and the like to obtain a finished product. The composition can be prepared into a suppository, a lotion and other dosage forms, and has application value in preparation of drugs for preventing or treating mixed vaginitis, especially mixed vaginitis caused by at least one of gardnerella and the like, and the preparation method is simple and easy to implement.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of traditional Chinese medicines, and in particular to an antibacterial gynecological composition, a preparation and a preparation method thereof. Background Art

[0002] With the acceleration of the pace of modern life and the improvement of women's health awareness, the incidence of gynecological inflammation, especially mixed vaginitis, has increased year by year, becoming an important health problem affecting women's quality of life. Vaginitis is one of the common gynecological diseases, which has a serious impact on women's physical and mental health. At present, the incidence of mixed vaginitis is on the rise. Its etiology is complex and is usually caused by the combined action of multiple pathogens, such as Gardnerella, Atopobium, Prevotella, Serratia and Peptostreptococcus. These bacteria may act alone or together to cause an imbalance in the vaginal microecology and trigger an inflammatory response. Its complexity and stubbornness bring challenges to clinical treatment.

[0003] Mixed vaginitis is usually caused by co-infection with two or more pathogenic microorganisms. The types and numbers of these pathogens may vary from person to person. Traditional treatment methods mostly rely on antibiotics, but long-term use can easily lead to the emergence of drug-resistant strains, and it is difficult to fully cover all pathogens. Common antimicrobial drugs may only be effective against a single pathogen and have poor therapeutic effects on mixed infections. Moreover, long-term use of a single antimicrobial drug can easily lead to drug resistance in pathogens, making treatment more difficult. Long-term use may also lead to drug resistance problems and microecological imbalance. Summary of the invention

[0004] In view of this, the present invention proposes an antibacterial gynecological composition, preparation and preparation method to solve the above problems.

[0005] The technical solution of the present invention is achieved as follows: an antibacterial gynecological composition: the active ingredients include the following raw materials in parts by weight: 55-65 parts of hesperidin, 35-55 parts of isatis indigotica, 23-43 parts of isatis root, 18-25 parts of houttuynia cordata, 10-20 parts of seven-leaf gentiana, 12-23 parts of dandelion, 14-19 parts of wormwood, 8-12 parts of allicin, 7-10 parts of lysozyme, 4-8 parts of shikimic acid, 2-5 parts of gallic acid, and 4-6 parts of purslane extract.

[0006] Furthermore, the active ingredients include the following raw materials in parts by weight: 60 parts of hesperidin, 45 parts of isatis indigotica, 33 parts of isatis root, 22 parts of houttuynia cordata, 15 parts of seven-leaf gentiana, 18 parts of dandelion, 17 parts of wormwood, 10 parts of allicin, 8 parts of lysozyme, 6 parts of shikimic acid, 3 parts of gallic acid, and 5 parts of purslane extract.

[0007] Furthermore, the active ingredient also includes the following raw materials in parts by weight: 10-13 parts of nano silver ion-chitosan complex, 5-15 parts of tea tree polysaccharide, and 8-12 parts of snail mucus antibacterial peptide.

[0008] Furthermore, the nano silver ion-chitosan complex is prepared by dissolving chitosan powder in acetic acid with a concentration of 0.1-0.3M, stirring for 30-50 minutes until it is completely dissolved to obtain a chitosan solution with a mass concentration of 60-80%, placing the chitosan solution in an ultrasonic reactor and stirring it, slowly dropping a silver nitrate solution into the chitosan solution, adding ascorbic acid to the mixed solution under the action of ultrasound, and continuing to stir for 15-35 minutes to form a nano silver ion-chitosan complex.

[0009] Furthermore, the ultrasonic power is 100-300W, the ultrasonic frequency is 55-100KHz, and the ultrasonic time is 15-30min.

[0010] Furthermore, the snail mucus antimicrobial peptide is prepared by adjusting the pH value of the collected snail mucus to 6.5-7.5, adding neutral protease, the amount of enzyme added is usually 0.1-3% (w / v) of the volume of the snail mucus, heating and stirring at 40-60°C, performing enzymatic hydrolysis reaction, the enzymatic hydrolysis time is 2-4h, and separating and purifying to obtain the snail mucus antimicrobial peptide.

[0011] Furthermore, the preparation is in the form of a suppository, lotion, gel, spray or ointment.

[0012] Furthermore, a method for preparing an antibacterial gynecological composition comprises the following steps:

[0013] S1. Processing Chinese herbal medicines: Wash and dry the Folium Isatidis, Radix Isatidis, Houttuynia cordata, Herba Polygoni Multiflori, Taraxaci, and Folium Artemisiae Argyi respectively, and then grind them into coarse powder;

[0014] S2, respectively put the crushed isatis indigofera, isatis root, houttuynia cordata, seven-leaf schizonepeta, dandelion, and wormwood coarse powder into an extraction container, add 3-7 times the mass of water of the mixture, heat and reflux at 60-80°C for 2-3 times, each time for 1-2 hours, combine the extracts, filter, and concentrate to an extract with a relative density of 1.1-1.2;

[0015] S3, mixing: adding hesperidin, allicin, lysozyme, shikimic acid, gallic acid, purslane extract, nano silver ion-chitosan complex, tea tree polysaccharide and snail mucus antimicrobial peptide to the above extract, and stirring evenly;

[0016] S4, drying: spray drying or vacuum drying the mixed materials to obtain dry powder;

[0017] S5, crushing and sieving: crush the dried powder and pass it through an 80-100 mesh sieve to obtain a uniform powder;

[0018] S6. Sterilization and packaging: sterilize the powder and then package it according to the prescribed dosage to obtain the antibacterial gynecological composition.

[0019] Furthermore, an antibacterial gynecological composition is used in the preparation of a drug for preventing or treating mixed vaginitis.

[0020] Furthermore, the Chinese medicine composition is used in the preparation of a drug for preventing or treating mixed vaginitis caused by at least one of the genus Gardnerella, Atopobium, Prevotella, Serratia or Megasphaera.

[0021] Compared with the prior art, the present invention has the following beneficial effects:

[0022] The present invention aims to provide an antibacterial gynecological composition, which forms a multi-target, multi-mechanism antibacterial system by scientifically proportioning a variety of natural plant extracts and bioactive ingredients, such as hesperidin, isatis indigo leaf, isatis root, houttuynia cordata, etc., combined with modern biotechnology products such as nano silver ion-chitosan complex, tea tree polysaccharide and snail mucus antimicrobial peptide. The composition can not only effectively inhibit and kill a variety of pathogens, but also promote the restoration of vaginal microecological balance and improve the body's immunity, thereby achieving the prevention and treatment of mixed vaginitis.

[0023] The preparation process of the present invention is simple, the raw materials are widely available and safe and non-toxic, and the finished product dosage forms are diverse, meeting the use needs of different patients. Through systematic and comprehensive preclinical research and preliminary clinical trial verification, the antibacterial gynecological composition shows good efficacy and safety, providing a new option for the treatment of mixed vaginitis. DETAILED DESCRIPTION

[0024] In order to better understand the technical content of the present invention, specific embodiments are provided below to further illustrate the present invention.

[0025] Unless otherwise specified, the experimental methods used in the embodiments of the present invention are all conventional methods.

[0026] Unless otherwise specified, the materials, reagents, etc. used in the embodiments of the present invention can be obtained from commercial sources.

[0027] The following introduces the basic information of the main raw materials based on the "Chinese Pharmacopoeia", "Chinese Materia Medica Dictionary" and "Chinese Herbal Medicine".

[0028]

Isatis indigo leaf

[0029] Nature and flavor: bitter, cold in nature.

[0030] Meridians: Heart and stomach meridians.

[0031] Functions and indications: Clearing away heat and detoxifying, cooling blood and removing spots. Used for high fever, coma, spots and rashes, mumps, throat paralysis, erysipelas, and carbuncle due to febrile diseases.

[0032]

Isatis root

[0033] Nature and flavor: bitter, cold in nature.

[0034] Meridians: Heart and stomach meridians.

[0035] Functions and indications: clearing away heat and detoxifying, cooling blood and relieving sore throat. Used for epidemic toxins, fever and sore throat, fever and toxins causing spots, mumps, sore throat, red sha, big head plague, erysipelas, carbuncle.

[0036]

Houttuynia cordata

[0037] Nature and flavor: spicy, slightly cold.

[0038] Meridian: Lung meridian.

[0039] Functions and indications: clearing away heat and detoxifying, eliminating carbuncle and draining pus, promoting diuresis and relieving stranguria. Used for lung carbuncle with pus vomiting, phlegm-heat cough and wheezing, hot dysentery, hot stranguria, carbuncle, swelling and ulcer.

[0040]

Seven-leaf flower

[0041] Nature and flavor: bitter, cold, slightly toxic.

[0042] Meridians: Liver meridian.

[0043] Functions and indications: Clearing away heat and detoxifying, relieving swelling and pain, cooling the liver and calming convulsions. Used for furuncle, carbuncle, sore throat, snake and insect bites, injuries from falls, convulsions.

[0044] Dandelion

[0045] Nature and flavor: bitter, sweet, cold.

[0046] Meridians: Liver and stomach meridians.

[0047] Functions and indications: clearing away heat and detoxifying, reducing swelling and dispersing stagnation, promoting diuresis and relieving stranguria. Used for carbuncle, breast carbuncle, scrofula, red eyes, sore throat, lung carbuncle, intestinal carbuncle, damp-heat jaundice, and painful stranguria caused by heat.

[0048] [Artemisia argyi]

[0049] Nature and flavor: pungent, bitter, warm; slightly toxic.

[0050] Meridians: Liver, spleen and kidney meridians.

[0051] Functions and indications: warms the meridians and stops bleeding, dispels cold and stops pain; externally used to dispel dampness and stop itching. Used for vomiting blood, epistaxis, metrorrhagia, menorrhagia, fetal bleeding, cold pain in the lower abdomen, irregular menstruation, and infertility caused by cold uterus; externally used to treat skin itching. Vinegar, moxa and charcoal warm the meridians and stop bleeding, and are used for bleeding caused by deficiency and cold.

[0052] Example 1

[0053] An antibacterial gynecological composition, wherein the active ingredients include the following raw materials in parts by weight: 55 parts of hesperidin, 35 parts of isatis indigotica, 23 parts of isatis root, 18 parts of houttuynia cordata, 10 parts of seven-leaf gentiana, 12 parts of dandelion, 14 parts of wormwood, 8 parts of allicin, 7 parts of lysozyme, 4 parts of shikimic acid, 2 parts of gallic acid, 4 parts of purslane extract, 10 parts of nano silver ion-chitosan complex, 5 parts of tea tree polysaccharide, and 8 parts of snail mucus antimicrobial peptide;

[0054] The nano silver ion-chitosan complex is prepared by dissolving chitosan powder in 0.1M acetic acid, stirring for 30 minutes until completely dissolved, to obtain a chitosan solution with a mass concentration of 60%, placing the chitosan solution in an ultrasonic reactor and stirring, wherein the ultrasonic power is 100W, the ultrasonic frequency is 55KHz, and the ultrasonic wave is performed for 15 minutes, and a silver nitrate solution is slowly added dropwise to the chitosan solution, and under the action of ultrasonic waves, ascorbic acid is added to the mixed solution, and stirring is continued for 15 minutes to form a nano silver ion-chitosan complex;

[0055] The snail mucus antimicrobial peptide is prepared by adjusting the pH value of the collected snail mucus to 6.5, adding neutral protease, the amount of enzyme added is usually 0.1% (w / v) of the volume of the snail mucus, heating and stirring at 40°C, performing enzymatic hydrolysis reaction, the enzymatic hydrolysis time is 2h, separating and purifying, and obtaining the snail mucus antimicrobial peptide.

[0056] Example 2

[0057] An antibacterial gynecological composition, the active ingredients comprising the following raw materials in parts by weight: 65 parts of hesperidin, 55 parts of isatis indigofera, 43 parts of isatis root, 25 parts of houttuynia cordata, 20 parts of seven-leaf gentiana, 23 parts of dandelion, 19 parts of wormwood, 12 parts of allicin, 10 parts of lysozyme, 8 parts of shikimic acid, 5 parts of gallic acid, 6 parts of purslane extract, 13 parts of nano silver ion-chitosan complex, 15 parts of tea tree polysaccharide, and 12 parts of snail mucus antimicrobial peptide;

[0058] The nano silver ion-chitosan complex is prepared by dissolving chitosan powder in 0.3M acetic acid, stirring for 50 minutes until completely dissolved, to obtain a chitosan solution with a mass concentration of 80%, placing the chitosan solution in an ultrasonic reactor and stirring, wherein the ultrasonic power is 300W, the ultrasonic frequency is 100KHz, and the ultrasonic wave is performed for 30 minutes, and a silver nitrate solution is slowly added dropwise to the chitosan solution, and under the action of ultrasonic waves, ascorbic acid is added to the mixed solution, and stirring is continued for 35 minutes to form a nano silver ion-chitosan complex;

[0059] The snail mucus antimicrobial peptide is prepared by adjusting the pH value of the collected snail mucus to 7.5, adding neutral protease, the amount of enzyme added is usually 3% (w / v) of the volume of the snail mucus, heating and stirring at 60°C, performing enzymatic hydrolysis reaction for 4 hours, separating and purifying, and obtaining the snail mucus antimicrobial peptide.

[0060] Example 3

[0061] An antibacterial gynecological composition, the active ingredients comprising the following raw materials in parts by weight: 60 parts of hesperidin, 45 parts of isatis indigotica, 33 parts of isatis root, 22 parts of houttuynia cordata, 15 parts of seven-leaf gentiana, 18 parts of dandelion, 17 parts of wormwood, 10 parts of allicin, 8 parts of lysozyme, 6 parts of shikimic acid, 3 parts of gallic acid, 5 parts of purslane extract, 12 parts of nano silver ion-chitosan complex, 10 parts of tea tree polysaccharide, and 10 parts of snail mucus antimicrobial peptide;

[0062] The nano silver ion-chitosan complex is prepared by dissolving chitosan powder in 0.2M acetic acid, stirring for 40 minutes until completely dissolved, to obtain a chitosan solution with a mass concentration of 70%, placing the chitosan solution in an ultrasonic reactor and stirring, wherein the ultrasonic power is 200W, the ultrasonic frequency is 70KHz, and the ultrasonic wave is performed for 25 minutes, and a silver nitrate solution is slowly added dropwise to the chitosan solution, and under the action of ultrasonic waves, ascorbic acid is added to the mixed solution, and stirring is continued for 25 minutes to form a nano silver ion-chitosan complex;

[0063] The snail mucus antimicrobial peptide is prepared by adjusting the pH value of the collected snail mucus to 7, adding a neutral protease, wherein the amount of the enzyme added is usually 2% (w / v) of the volume of the snail mucus, heating and stirring at 50° C., performing an enzymatic hydrolysis reaction for 3 hours, and separating and purifying to obtain the snail mucus antimicrobial peptide;

[0064] The above examples 1-3 adopt the following preparation method:

[0065] S1. Processing Chinese herbal medicines: Wash and dry the Folium Isatidis, Radix Isatidis, Houttuynia cordata, Herba Polygoni Multiflori, Taraxaci, and Folium Artemisiae Argyi respectively, and then grind them into coarse powder;

[0066] S2. Put the crushed isatis indigofera, isatis root, houttuynia cordata, seven-leaf lily, dandelion and wormwood powder into the extraction container respectively, add 5 times of water by weight of the mixture, heat and reflux at 70°C for 3 times, each time for 1 hour, combine the extracts, filter and concentrate to an extract with a relative density of 1.1;

[0067] S3, mixing: adding hesperidin, allicin, lysozyme, shikimic acid, gallic acid, purslane extract, nano silver ion-chitosan complex, tea tree polysaccharide and snail mucus antimicrobial peptide to the above extract, and stirring evenly;

[0068] S4, drying: spray drying the mixed material to obtain dry powder;

[0069] S5, crushing and sieving: crush the dried powder and pass it through a 90-mesh sieve to obtain a uniform powder;

[0070] S6. Sterilization and packaging: sterilize the powder and then package it according to the prescribed dosage to obtain the antibacterial gynecological composition.

[0071] Comparative Example 1

[0072] The difference between this comparative example and Example 3 is that the active ingredients of the antibacterial gynecological composition include the following raw materials in parts by weight: 40 parts of hesperidin, 30 parts of isatis indigotica, 20 parts of isatis root, 15 parts of houttuynia cordata, 22 parts of seven-leaf gentiana, 25 parts of dandelion, 10 parts of wormwood, 5 parts of allicin, 5 parts of lysozyme, 12 parts of shikimic acid, 7 parts of gallic acid, 2 parts of purslane extract, 8 parts of nano silver ion-chitosan complex, 17 parts of tea tree polysaccharide, and 15 parts of snail mucus antibacterial peptide.

[0073] Comparative Example 2

[0074] The difference between this comparative example and Example 3 is that the antibacterial gynecological composition does not contain the nano silver ion-chitosan complex.

[0075] Comparative Example 3

[0076] The difference between this comparative example and Example 3 is that the antibacterial gynecological composition does not contain snail mucus antibacterial peptides.

[0077] 1. Antibacterial experiment

[0078] Test samples: antibacterial gynecological compositions of Examples 1-3 and Comparative Examples 1-3

[0079] Control sample: Metronidazole

[0080] Strains: standard strains of Gardnerella, Atopobium, Prevotella, Serratia, and Megasphaera;

[0081] (I) Preparation of bacterial solution

[0082] 1. Take 1g of bacterial moss from each frozen standard strain and inoculate it into the corresponding fresh culture medium.

[0083] 2. Incubate the inoculated culture medium at 25°C for 18-24 hours to activate the strain.

[0084] 3. Dilute the activated cultures of each strain with physiological saline to a bacterial concentration of 1×106 CFU / mL (determined by turbidimetry or plate count method).

[0085] (II) Drug dilution

[0086] 1. Dilute the tested antibacterial gynecological composition and control drug 50 times with sterile saline.

[0087] 2. Label each group of liquid medicine separately.

[0088] (III) Agar plate diffusion method

[0089] 1. Take an appropriate amount of each bacterial solution with adjusted concentration and spread it evenly on the surface of the corresponding agar plate.

[0090] 2. Use sterile tweezers to gently place the sterilized Oxford cups on the agar plate. Place 3-4 Oxford cups on each plate, and the distance between the cups should be equal.

[0091] 3. Add different concentrations of test solution and control solution into each Oxford cup, being careful not to overflow.

[0092] 4. Place the plate with the sample in suitable culture conditions and culture for 18-24 hours.

[0093] (IV) Observation and measurement of results

[0094] 1. After the culture is completed, observe whether there is an inhibition zone on the plate.

[0095] 2. Use a vernier caliper to measure the diameter of the inhibition zone and record the result.

[0096] (V) Data Analysis

[0097] 1. Compare the diameters of the inhibition zones produced by the test drug and the control drug at different concentrations for each strain.

[0098] 2. Judge the antibacterial effect of the drug based on the diameter of the inhibition zone. The larger the diameter of the inhibition zone, the stronger the antibacterial effect.

[0099] (VI) Data Results

[0100]

[0101]

[0102] In Examples 1-3, for Gardnerella, Atopobium, Prevotella, Serratia and Megasphaera, a large diameter of the inhibition zone was shown, indicating that the antibacterial gynecological composition in these three examples has a strong antibacterial ability. Among them, the effect of Example 3 is relatively more prominent, and the diameter of the inhibition zone is the largest in the inhibition of most bacterial genera, such as the diameter of the inhibition zone for Prevotella reaches 17.5 mm, and for Megasphaera reaches 14.2 mm;

[0103] The diameters of the inhibition zones of Comparative Examples 1-3 are smaller than those of Examples 1-3 as a whole, indicating that the antibacterial effects thereof are relatively weak. Compared with the control group, the diameters of the inhibition zones of Examples 1-3 and Comparative Examples 1-3 are significantly larger, indicating that all the tested antibacterial gynecological compositions have a significant antibacterial effect compared with the control group without any active ingredient added.

[0104] In general, the antibacterial gynecological compositions of Examples 1-3 performed well in inhibiting Gardnerella, Atopobium, Prevotella, Serratia and Megasphaera, especially Example 3 had the best effect. Although Comparative Examples 1-3 also had a certain antibacterial effect, it was not as significant as the Examples. This shows that the formula or preparation method of the antibacterial gynecological composition in the Examples may be more conducive to exerting an antibacterial effect and is worthy of further research and development.

[0105] Compared with comparative example 2, in example 3, silver ions are dispersed in the chitosan matrix at the atomic level to form nanometer microspheres, and stable coating is achieved through electrostatic interaction. The composite exhibits good antibacterial effect in a simulated vaginal environment.

[0106] Compared with Comparative Example 3, Example 3 shows that the snail mucus antimicrobial peptides are derived from natural products and contain a variety of components that promote cell migration and proliferation. The antimicrobial peptides bind to the cell membrane of microorganisms, destroy their structure, and cause the leakage of cell contents, thereby achieving a bactericidal effect, which makes it have a significant effect in the treatment of gynecological diseases caused by these microorganisms.

[0107] 2. Clinical efficacy

[0108] 1. Experimental design

[0109] This trial adopted a randomized, double-blind, placebo-controlled, multicenter study design.

[0110] 2. Study population

[0111] 130 female patients aged between 18 and 50 years old.

[0112] 2. Clinical diagnosis of vaginitis, and the causative bacteria are at least one of the genus Gardnerella, Atopobium, Prevotella, Serratia or Megasphaera.

[0113] 3 Volunteer to participate in this trial and sign the informed consent.

[0114] (III) Exclusion criteria

[0115] 1. Those who are allergic to the experimental drug or its ingredients.

[0116] 2. Pregnant or lactating women.

[0117] 3. Combined with other serious gynecological diseases or systemic diseases.

[0118] 4. Used other antibacterial drugs or received related treatments in the past month.

[0119] (IV) Experimental Grouping

[0120] Experimental group: treated with the antibacterial gynecological composition of Example 3.

[0121] Control group: treated with placebo.

[0122] (V) Treatment plan

[0123] Experimental group: According to the prescribed dosage and method of use, the antibacterial gynecological composition was used to make suppositories, once a day, for a course of 2 weeks.

[0124] Control group: A placebo with the same appearance, smell and usage method as the experimental group is used. The frequency of use and course of treatment are the same as those of the experimental group.

[0125] (VI) Observation indicators

[0126] 1. Main efficacy indicators: Improvement of vaginitis symptoms before and after treatment, evaluated using a symptom rating scale.

[0127] Itch: 0 (no itching), 1 (mild itching, not affecting daily life), 2 (moderate itching, occasionally affecting daily life), 3 (severe itching, seriously affecting daily life)

[0128] Odor: 0 (no odor), 1 (slight odor), 2 (moderate odor), 3 (strong odor)

[0129] Abnormal leucorrhea: 0 point (normal), 1 point (mild increase, slight change in texture), 2 points (significant increase, change in texture), 3 points (large increase, purulent or bloody leucorrhea).

[0130] Pathogenic examination: Determine the presence of pathogenic bacteria through pathogenic examination (such as culture, smear, etc.), and test the clearance rate of pathogenic bacteria before and after treatment

[0131] Clearance rate = (number of pathogen-positive cases before treatment - number of pathogen-positive cases after treatment) / number of pathogen-positive cases before treatment × 100%.

[0132] 2. Secondary efficacy indicators: changes in pH value of vaginal secretions and improvements in vaginal cleanliness.

[0133] Vaginal cleanliness:

[0134]

[0135] Good rate (%) = (number of patients with improved vaginal cleanliness ÷ total number of patients) × 100%;

[0136] Observe and record adverse events that occur during the treatment, such as local irritation, allergic reactions, etc.

[0137] (VII) Experimental results

[0138]

[0139]

[0140] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. An antibacterial gynecological composition, characterized in that: The active ingredients include the following raw materials in parts by weight: 55-65 parts of hesperidin, 35-55 parts of isatis indigotica, 23-43 parts of isatis root, 18-25 parts of houttuynia cordata, 10-20 parts of scutellaria baicalensis, 12-23 parts of dandelion, 14-19 parts of wormwood, 8-12 parts of allicin, 7-10 parts of lysozyme, 4-8 parts of shikimic acid, 2-5 parts of gallic acid, and 4-6 parts of purslane extract.

2. An antibacterial gynecological composition according to claim 1, characterized in that: The active ingredients include the following raw materials in parts by weight: 60 parts of hesperidin, 45 parts of isatis indigotica, 33 parts of isatis root, 22 parts of houttuynia cordata, 15 parts of seven-leaf gentiana, 18 parts of dandelion, 17 parts of wormwood, 10 parts of allicin, 8 parts of lysozyme, 6 parts of shikimic acid, 3 parts of gallic acid, and 5 parts of purslane extract.

3. An antibacterial gynecological composition according to claim 1, characterized in that: The active ingredients also include the following raw materials in parts by weight: 10-13 parts of nano silver ion-chitosan complex, 5-15 parts of tea tree polysaccharide, and 8-12 parts of snail mucus antibacterial peptide.

4. The antibacterial gynecological preparation according to claim 3, characterized in that: The nano silver ion-chitosan complex is prepared by dissolving chitosan powder in acetic acid with a concentration of 0.1-0.3M, stirring for 30-50 minutes until it is completely dissolved to obtain a chitosan solution with a mass concentration of 60-80%, placing the chitosan solution in an ultrasonic reactor for stirring, slowly dropping a silver nitrate solution into the chitosan solution, adding ascorbic acid to the mixed solution under the action of ultrasonic waves, and continuing to stir for 15-35 minutes to form a nano silver ion-chitosan complex.

5. The antibacterial gynecological preparation according to claim 4, characterized in that: The ultrasonic power is 100-300W, the ultrasonic frequency is 55-100KHz, and the ultrasonic duration is 15-30min.

6. The antibacterial gynecological preparation according to claim 3, characterized in that: The snail mucus antimicrobial peptide is prepared by adjusting the pH value of the collected snail mucus to 6.5-7.5, adding neutral protease, the amount of enzyme added is usually 0.1-3% (w / v) of the volume of the snail mucus, heating and stirring at 40-60°C, performing enzymatic hydrolysis reaction for 2-4 hours, separating and purifying, and obtaining the snail mucus antimicrobial peptide.

7. The antibacterial gynecological preparation according to claim 1, characterized in that: The preparation is in the form of suppository, lotion, gel, spray or ointment.

8. The method for preparing an antibacterial gynecological composition according to claim 1, characterized in that: The following steps are involved: S1. Processing Chinese herbal medicines: Wash and dry the Folium Isatidis, Radix Isatidis, Houttuynia cordata, Herba Polygoni Multiflori, Taraxaci, and Folium Artemisiae Argyi respectively, and then grind them into coarse powder; S2, respectively put the crushed isatis indigofera, isatis root, houttuynia cordata, seven-leaf schizonepeta, dandelion, and wormwood coarse powder into an extraction container, add 3-7 times the mass of water of the mixture, heat and reflux at 60-80°C for 2-3 times, each time for 1-2 hours, combine the extracts, filter, and concentrate to an extract with a relative density of 1.1-1.2; S3, mixing: adding hesperidin, allicin, lysozyme, shikimic acid, gallic acid, purslane extract, nano silver ion-chitosan complex, tea tree polysaccharide and snail mucus antimicrobial peptide to the above extract, and stirring evenly; S4, drying: spray drying or vacuum drying the mixed materials to obtain dry powder; S5, crushing and sieving: crush the dried powder and pass it through an 80-100 mesh sieve to obtain a uniform powder; S6. Sterilization and packaging: sterilize the powder and then package it according to the prescribed dosage to obtain the antibacterial gynecological composition.

9. Use of the antibacterial gynecological composition according to claim 1 in the preparation of a medicament for preventing or treating mixed vaginitis.

10. Use of the Chinese medicine composition according to claim 9 in the preparation of a medicament for preventing or treating mixed vaginitis caused by at least one of the genus Gardnerella, Atopobium, Prevotella, Serratia or Megasphaera.

Citation Information

Patent Citations

  • Chitosan gel dropping pill for gynaecologic bacteriostasis and preparation method thereof

    CN104257620A

  • Method for preparing biological active peptide by conducting hydrolysis on snail protein through enzymatic method

    CN105132511A

  • Gynaecological antibacterial gel and preparation method thereof

    CN107468639A

  • Antibacterial firming gel formula

    CN108478523A

  • Medicine composition for treating gynecologic inflammation and preparation method thereof

    CN108567958A